These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 14168867)

  • 1. SOMATIC MANIFESTATIONS IN PATIENTS GIVEN PSYCHOPHARMACOTHERAPY.
    GOOSZEN JA
    Psychiatr Neurol Neurochir; 1964; 67():123-9. PubMed ID: 14168867
    [No Abstract]   [Full Text] [Related]  

  • 2. [ON THE SIGNIFICANCE OF ASSOCIATED NEUROLOGIC DISORDERS IN TREATMENTS BY NEUROLEPTICS].
    SIZARET P; CHALLOU C
    Therapie; 1963; 18():1453-61. PubMed ID: 14117541
    [No Abstract]   [Full Text] [Related]  

  • 3. [CLINICAL FEATURES AND THERAPY OF TOXIC ENCEPHALOPATHIES].
    ROZENTSVIT GE; ASANOVA TP
    Gig Tr Prof Zabol; 1963 Jul; 7():22-7. PubMed ID: 14074260
    [No Abstract]   [Full Text] [Related]  

  • 4. [MODIFICATIONS OF HEPATIC FUNCTION AFTER PROLONGED TREATMENT WITH BUTYRYLPERAZINE].
    LAPAGLIA S; ANDREANI G
    G Psichiatr Neuropatol; 1964; 92():693-710. PubMed ID: 14249249
    [No Abstract]   [Full Text] [Related]  

  • 5. NEUROLOGICAL SYMPTOMS IN PHARMACOTHERAPY OF PSYCHOSES.
    Faurbye A; Rasch PJ; Petersen PB; Brandborg G; Pakkenberg H
    Acta Psychiatr Scand; 1964; 40(1):10-27. PubMed ID: 14217630
    [No Abstract]   [Full Text] [Related]  

  • 6. A neurological complication in children on phenothiazine tranquillizers.
    EHRLICH RM
    Can Med Assoc J; 1959 Aug; 81(4):241-3. PubMed ID: 13819617
    [No Abstract]   [Full Text] [Related]  

  • 7. ADVERSE REACTIONS TO PHENOTHIAZINES.
    HOLLISTER LE
    JAMA; 1964 Jul; 189():311-3. PubMed ID: 14160497
    [No Abstract]   [Full Text] [Related]  

  • 8. [COMPLICATIONS DURING CLINICAL THERAPY WITH PSYCHOPHARMACA].
    HAEFNER H; KUTSCHER I
    Arztl Forsch; 1964 Jan; 18():18-36. PubMed ID: 14140626
    [No Abstract]   [Full Text] [Related]  

  • 9. PHENOTHIAZINES, SKIN PIGMENTATION AND RELATED EYE FINDINGS.
    BRILL H; SCHEIE HG; DELONG SL
    Am J Psychiatry; 1965 Sep; 122():326-7. PubMed ID: 14327477
    [No Abstract]   [Full Text] [Related]  

  • 10. COMPLICATIONS FROM PSYCHOTHERAPEUTIC DRUGS--1964.
    HOLLISTER LE
    Clin Pharmacol Ther; 1964; 5():322-33. PubMed ID: 14168522
    [No Abstract]   [Full Text] [Related]  

  • 11. EVALUATION OF A NEW PHENOTHIAZINE DERIVATIVE IN THE TREATMENT OF SCHIZOPHRENIA.
    GERZ HO
    Am J Psychiatry; 1964 Aug; 121():174-6. PubMed ID: 14194215
    [No Abstract]   [Full Text] [Related]  

  • 12. [PROBLEMS RAISED BY THE PROLONGED USE OF NEUROLEPTICS AND ANTIDEPRESSANTS. (SIGNIFICANCE OF THE STUDY OF NEUROMUSCULAR EXCITABILITY AND THE RATIO NAPL-KGB)].
    POUGETOUX J; VIADER A; CAMPAGNOLLE A
    Ann Med Psychol (Paris); 1964 Jan; 122():61-90. PubMed ID: 14131351
    [No Abstract]   [Full Text] [Related]  

  • 13. A SYNDROME OF ABNORMAL MOVEMENTS AND DEMENTIA IN LEUCOTOMIZED PATIENTS TREATED WITH PHENOTHIAZINES.
    HUNTER R; EARL CJ; JANZ D
    J Neurol Neurosurg Psychiatry; 1964 Jun; 27(3):219-23. PubMed ID: 14175288
    [No Abstract]   [Full Text] [Related]  

  • 14. A LONG-TERM CLINICAL EVALUATION OF A NEW TRANQUILLIZER--TOLNATE.
    FISMER DF
    S Afr Med J; 1964 Nov; 38():911-3. PubMed ID: 14225676
    [No Abstract]   [Full Text] [Related]  

  • 15. THIOPROPERAZINE IN CHRONIC SCHIZOPHRENIA.
    HORDERN A; KING A; HOLT NF; COLLINS HJ; TOUSSAINT J
    Br J Psychiatry; 1964 Jul; 110():531-9. PubMed ID: 14153363
    [No Abstract]   [Full Text] [Related]  

  • 16. A PRELIMINARY EVALUATION OF SKF 20,716 (PROPERICIAZINE) IN CHRONIC SCHIZOPHRENIC PATIENTS.
    GALLANT DM; BISHOP MP; GALLANT JC
    Curr Ther Res Clin Exp; 1964 Sep; 6():597-8. PubMed ID: 14208737
    [No Abstract]   [Full Text] [Related]  

  • 17. [CLINICAL OBSERVATIONS ON THE ACTION OF TINDAL IN PSYCHIATRIC TREATMENT].
    BORZYCH D; GALUSZKO P
    Neurol Neurochir Psychiatr Pol; 1964; 14():683-6. PubMed ID: 14249556
    [No Abstract]   [Full Text] [Related]  

  • 18. [Normalization of the affective-autonomic complex].
    BIRKMAYER W; NEUMAYER E
    Dtsch Med J; 1962 Jul; 13():433-7. PubMed ID: 13869405
    [No Abstract]   [Full Text] [Related]  

  • 19. [NEUROLOGICAL COMPLICATIONS IN THE COURSE OF TREATMENT WITH NEUROLEPTICS IN THE LIGHT OF HISTOPATHOLOGICAL INVESTIGATIONS].
    JANKOWSKI K
    Neurol Neurochir Psychiatr Pol; 1964; 14():635-41. PubMed ID: 14249549
    [No Abstract]   [Full Text] [Related]  

  • 20. WITHDRAWAL SYMPTOMS AFTER ABRUPT CESSATION OF ANTIPSYCHOTIC COMPOUNDS: CLINICAL CONFIRMATION IN CHRONIC SCHIZOPHRENICS.
    GALLANT DM; EDWARDS CG; BISHOP MP; GALBRAITH GC
    Am J Psychiatry; 1964 Nov; 121():491-3. PubMed ID: 14218408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.